| Prev Close | 4.10 |
| Open | 4.22 |
| Day Low/High | 3.98 / 4.33 |
| 52 Wk Low/High | 4.01 / 26.73 |
| Volume | 346.21K |
Tekmira Announces Update To Its Proxy Circular On The Proposed Business Combination With OnCore Biopharma Inc.
Board Nominees Complete for Combined Company
Tekmira Announces Filing Of Definitive Proxy Statement And Voluntary Delisting From The TSX
Special Meeting of Shareholders to be Held March 3, 2015
Prepare for Volatility in the Morning
But I'm most uneasy with unimpressive action in individual stocks.
Tekmira Initiates Phase I Clinical Trial Of TKM-HBV
TKM-HBV, a Leading RNAi Approach to Reduce Hepatitis B Surface Antigen, Has the Potential to Play a Central Role in the Cure of Chronic Hepatitis B Virus Infection
Tekmira Pharmaceuticals (TKMR) Weak On High Volume
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a weak on high relative volume candidate
Perilous Reversal Watch: Tekmira Pharmaceuticals (TKMR)
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate
Tekmira Pharmaceuticals (TKMR) Stock Soars After OnCore Biopharma Acquisition Announcement
Shares of Tekmira Pharmaceuticals (TKMR) surged in morning trading Monday after the company agreed to acquire OnCore Biopharma to shift focus to developing hepatitis B virus treatments.
Heavy Trading On Tekmira Pharmaceuticals (TKMR) Before Market Open
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a pre-market mover with heavy volume candidate
Tekmira Pharmaceuticals (TKMR) Stock Surges Today After Clinical Study Update
Shares of Tekmira Pharmaceuticals (TKMR) spiked Wednesday after the company provided an update on a Phase I/II clinical study.
Tekmira Pharmaceuticals (TKMR) Is Today's Strong On High Volume Stock
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a strong on high relative volume candidate
Tekmira Receives Clearance To Conduct A Phase I Clinical Study With TKM-HBV
TKM-HBV is Designed to Treat Patients Chronically Infected With Hepatitis B Virus
Tekmira Pharmaceuticals (TKMR) Flagged As Strong On High Volume
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a strong on high relative volume candidate
'Mad Money' Lightning Round: I'll Take Popeye's Over Wendy's
Cramer can't recommend Dynavax Technologies but wants you to hold Noble Energy.
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
Cramer will be listening to conference calls next week but says a lot of the companies are better than their stocks.
Tekmira Pharmaceuticals (TKMR) Showing Signs Of Perilous Reversal Today
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate
Tekmira Announces Licensing And Collaboration Agreement With Dicerna
Tekmira's LNP to Enable Dicerna's PH1 Candidate
One Factor Driving Tekmira Pharmaceuticals (TKMR) Stock Down Today
Shares of Tekmira Pharmaceuticals (TKMR) are lower after the company's price target was lowered at Leerink Partners earlier on Monday.
Tekmira Provides Corporate Update And Announces Third Quarter 2014 Results
Conference Call at 5:00 pm Eastern Time Today
TKMR December 26th Options Begin Trading
Investors in Tekmira Pharmaceuticals Corp saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new December 26th contracts and identified one put and one call contract of particular interest.